Table 1

Patient and tumour characteristics*

Factor

AR negative n = 32 (%)

AR positiven = 41 (%)


Age (years)


≤35

1 (3.0)

1 (2.4)


≥35

31 (97.0)

40 (97.6)


Estrogen receptor


Negative

23 (72.0)

9 (22.5)


Positive

9 (28.0)

31 (77.5)


Progesterone receptor


Negative

27 (87.0)

16 (39.0)


Positive

4 (13.0)

25 (61.0)


HER2


Negative

18 (85.7)

25 (75.8)


Positive

3 (14.3)

8 (24.2)


Triple negativea


No

6 (28.6)

30 (90.9)


Yes

15 (71.4)

3 (9.1)


*All patients were diagnosed with Stage III disease, as defined in the Materials and Methods section of the manuscript

aTriple negative breast cancer represents tumours displaying negative expression for estrogen receptor, progesterone receptor and HER2 by IHC. AR, androgen receptor; HER2, human epidermal growth factor receptor type 2.

Peters et al. BMC Cancer 2012 12:132   doi:10.1186/1471-2407-12-132

Open Data